Instil Bio, Inc. (TIL)

Aspen Technology Statistics

Total Valuation

Instil Bio has a market cap or net worth of $147.60 million. The enterprise value is $137.44 million.

Market Cap	147.60M
Enterprise Value	137.44M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.56 million shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class	6.56M
Shares Outstanding	6.56M
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	9.11%
Owned by Institutions (%)	32.34%
Float	2.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.09
P/TBV Ratio	1.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 30.33, with a Debt / Equity ratio of 0.60.

Current Ratio	30.33
Quick Ratio	14.34
Debt / Equity	0.60
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.75

Financial Efficiency

Return on equity (ROE) is -44.50% and return on invested capital (ROIC) is -13.08%.

Return on Equity (ROE)	-44.50%
Return on Assets (ROA)	-12.59%
Return on Invested Capital (ROIC)	-13.08%
Return on Capital Employed (ROCE)	-23.79%
Revenue Per Employee	n/a
Profits Per Employee	-$5.57M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +82.51% in the last 52 weeks. The beta is 2.17, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	2.17
52-Week Price Change	+82.51%
50-Day Moving Average	27.65
200-Day Moving Average	23.42
Relative Strength Index (RSI)	40.11
Average Volume (20 Days)	232,204

Short Selling Information

The latest short interest is 1.13 million, so 17.20% of the outstanding shares have been sold short.

Short Interest	1.13M
Short Previous Month	1.02M
Short % of Shares Out	17.20%
Short % of Float	42.57%
Short Ratio (days to cover)	3.62

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-54.76M
Pretax Income	-123.32M
Net Income	-78.03M
EBITDA	-51.64M
EBIT	-54.76M
Earnings Per Share (EPS)	-$11.97

Balance Sheet

The company has $103.65 million in cash and $86.67 million in debt, giving a net cash position of $16.98 million or $2.59 per share.

Cash & Cash Equivalents	103.65M
Total Debt	86.67M
Net Cash	16.98M
Net Cash Per Share	$2.59
Equity (Book Value)	144.91M
Book Value Per Share	22.09
Working Capital	212.04M

Cash Flow

Operating Cash Flow	-45.50M
Capital Expenditures	n/a
Free Cash Flow	-45.50M
FCF Per Share	-$6.94

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.21%
Shareholder Yield	-0.21%
Earnings Yield	-50.53%
FCF Yield	-29.46%

Analyst Forecast

The average price target for Instil Bio is $119.00, which is 428.89% higher than the current price. The consensus rating is "Buy".

Price Target	$119.00
Price Target Difference	428.89%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2